Jacquelynn Lucas
Senior Director, Toxicology Crescent Biopharma
Seminars
Thursday 14th May 2026
Optimizing Starting Dose for Bispecifics to Enable Safe & Effective Firstin- Human Studies
9:30 am
- Appreciate the history of approved Bispecifics and the clinical landscape
- Understand regulatory and industry guidance as well as challenges that come with selecting starting dose for bispecifics in oncology indications
- Learn how integrated approaches can enable a safe starting dose while potentially accelerating dose escalation
